Fat suppression techniques (STIR vs. SPAIR) on diffusion-weighted imaging of breast lesions at 3.0 T: preliminary experience by Brandão, Sofia et al.
Fat suppression techniques (STIR vs. SPAIR) on diffusion‑weighted 
imaging of breast lesions  at 3.0 T: preliminary experience
Sofia Brandão · Luísa Nogueira · Eduarda Matos · Rita Gouveia Nunes · Hugo Alexandre Ferreira · Joana 
Loureiro · Isabel Ramos 
ratio (CNR), and apparent diffusion coefficient (ADC) val-
ues for normal gland, benign and malignant lesions were 
compared. Receiver operating characteristic analysis was 
also performed.
Results From the 52 lesions found, 47 were detected by 
both sequences. DWI-STIR evidenced more homogene-
ous fat suppression (p = 0.03). Although these lesions
were seen with both techniques, DWI-SPAIR evidenced 
higher score for lesion visibility in nine of them. SNR and 
CNR were comparable, except for SNR in benign lesions 
(p < 0.01), which was higher for DWI-SPAIR. Mean ADC 
values for lesions were similar. ADC for normal fibroglan-
dular tissue was higher when using DWI-STIR (p = 0.006).
Sensitivity, specificity, accuracy and area under the curve 
values were alike: 84.0 % for both; 77.3, 71.4 %; 80.9, 
78.3 %; 82.5, 81.3 % for DWI-SPAIR and DWI-STIR, 
respectively.
Abstract 
Purpose The aim of this work was to perform a qualita-
tive and quantitative comparison of the performance of two 
fat suppression techniques on breast diffusion-weighted 
imaging (DWI).
Materials and methods Fifty-one women underwent 
clinical breast magnetic resonance imaging, including 
DWI with short TI inversion recovery (STIR) and spectral 
attenuated inversion recovery (SPAIR). Four were excluded 
from the analysis due to image artefacts. Rating of fat sup-
pression uniformity and lesion visibility were performed. 
Agreement between the two sequences was evaluated. 
Additionally, signal-to-noise ratio (SNR), contrast-to-noise 
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Conclusion DWI-STIR showed superior fat suppres-
sion homogeneity. No differences were found for SNR and 
CNR, except for SNR in benign lesions. ADCs for lesions 
were comparable. Findings in this study are consistent with 
previous studies at 1.5 T, meaning that both fat suppression 
techniques are appropriate for breast DWI at 3.0 T.
Keywords Magnetic resonance imaging · Breast 
diffusion-weighted imaging · Fat suppression techniques · 
Image quality
Introduction
Research in breast magnetic resonance imaging (MRI) 
reports diffusion-weighted imaging (DWI) as a useful tech-
nique to improve lesion characterisation. To date, most 
of the published work relates to apparent diffusion coef-
ficient (ADC) quantification at 1.5 T [1, 2], and publica-
tions focusing on 3.0 T are still scarce. The ADC value 
quantifies the signal intensity attenuation between at least 
two diffusion-weighted images with different b values [3]. 
The signal intensity decrease depends on both tissue char-
acteristics and image parameters. Malignant breast lesions, 
usually display higher signal intensity when compared to 
normal tissue or benign lesions, reflecting more compact 
barriers to water motion [3]. Apart from tissue architecture, 
voxel signal intensity is also related to the pulse sequence 
parameters, e.g. echo time, matrix size, b value and the fat 
suppression technique.
Fat suppression is essential to eliminate the lipid sig-
nal and also to reduce image artefacts. If suppression is not 
homogeneous it may eventually impair lesion detection and 
ADC measurement [3]. Also, signal-to-noise ratio (SNR) 
and contrast-to-noise ratio (CNR) are strongly correlated 
with the quality of fat suppression. For that purpose, dif-
ferent techniques can be combined with breast DWI, each 
with their own advantages and drawbacks. Fat saturation 
(FatSat) methods are based on frequency-selective radiofre-
quency (RF) pulses that only excite fat spins. Chemical shift 
selective (CHESS) pulses are easily included in most pulse 
sequences but work poorly in regions with inhomogeneous 
B0 [4], which may lead to insufficient fat suppression, espe-
cially when compared to short TI inversion recovery (STIR) 
[5]. As STIR uses a spatially selective 180° RF pre-pulse 
with short inversion time to suppress lipid signal, it is a more 
robust approach to cope with B0 inhomogeneities and sus-
ceptibility changes [3–6]. Nevertheless, the fact that STIR 
leads to an inherent T1-weighting, suppressing signal from 
tissues with T1 similar to fat is a limiting factor to its use.
In the case of spectral pre-saturation with inversion 
recovery (SPIR) and spectrally attenuated inversion recov-
ery (SPAIR), spectral pre-saturation pulses are added to 
the inversion recovery module [7]. For T1- or T2-weighted 
fat suppression, SPAIR uses adiabatic (frequency-varying) 
inversion pulses [8] to invert fat spins, and a spoiler to 
destroy any residual transverse magnetisation. This process 
reduces the effect of B1 inhomogeneities, which are fre-
quent on high-field MRI, but increases RF absorption rate 
[9].
Given that signal intensity may depend on the fat sup-
pression technique, different options for breast DWI should 
be considered in the clinical setting, since it may affect 
lesion identification and the demarcation of the region-of-
interest (ROI) to calculate the ADC. This may have a true 
impact on lesion classification, as the ADC value is used to 
distinguish benign from malignant lesions [10, 11].
Therefore, the purpose of this study was to compare 
STIR and SPAIR for breast DWI at 3.0 T, through the eval-
uation of the homogeneity of fat suppression and lesion 
detection, SNR and CNR. The ADC values for normal 
tissue and lesions, and diagnostic performance were also 
compared.
Materials and methods
Patients
A prospective study was developed to analyse the use of 
DWI in breast MRI at 3.0 T. The focus was to evaluate 
lesion classification by investigating the influence of several 
parameters of DWI, namely the best set of b values, the fat 
suppression technique, and signal intensity fitting models.
This preliminary study was carried out between July 
2009 and January 2010, and includes the first sets of data. 
In that period, 51 women underwent clinical breast MRI 
with two different DWI pulse sequences. The Institutional 
Ethics Committee approved this work (protocol: CES 
276/13), and all the patients gave their written informed 
consent.
Reasons for breast MRI included: screening of women 
with BRCA1 and 2 (n = 5), evaluation of suspicious
lesions on ultrasound/mammography (n = 27); and pre-
surgical staging (n = 19).
Acquisitions for premenopausal patients were done 
between the 7th and the 14th day of their menstrual cycles 
to exclude effects of hormonal fluctuations on ADC [3, 
12]. Exclusion criteria included technical problems, patient 
noncooperation and motion artefacts. Histological results 
were the reference standards for lesion diagnosis.
MRI acquisition
The MR examinations were performed using a 3.0 T sys-
tem (MAGNETOM Tim Trio, Siemens Medical Solutions, 
Erlangen, Germany) equipped with a dedicated four-chan-
nel breast phased-array RF coil.
The MRI protocol included 5-mm-thick axial T2w-
FSE and sagittal STIR-FSE and DWI images, followed 
by a 0.9-mm-thick dynamic contrast-enhanced axial 
images, and 1-mm-thick sagittal T1w-GRE water exci-
tation post-contrast images. Single-shot-SE-EPI-STIR 
and -SPAIR pulse sequences with multiple b values were 
acquired unilaterally in the sagittal plane for both breasts 
before gadolinium injection. Parallel imaging (accelera-
tion factor of two), a saturation slab covering the thorax, 
and volume shimming were used [13]. Table 1 shows fur-
ther details. Total examination time was approximately 
38 min.
Image analysis
A senior radiologist, with 5 years experience on breast MRI 
(J.L.) prospectively reported the clinical MR examinations 
according to the BIRADS-MRI lexicon [14].
Conventional and DWI pulse sequences were transferred 
to a workstation. The dynamic contrast-enhanced acquisi-
tion was reconstructed a posteriori in the sagittal plane. To 
calculate the ADC value for this work, the monoexponen-
tial model was applied using the b values 50, 200, 400, 600, 
800 and 1,000 s/mm2.
Based on the lesion description in the clinical MR 
report, and using sagittal STIR-FSE and dynamic contrast-
enhanced images to locate them, two readers (S.B. and 
L.N.) analysed the DWI datasets in consensus. Readers 
were blinded to the histopathological results.
Visual assessment
Image quality was assessed for both uniformity of fat sup-
pression and lesion visibility. Uniformity of fat suppression 
was encoded as follows: 0—homogeneous fat suppression; 
1—evidence of heterogeneous fat suppression, though with 
no impairment in lesion analysis; 2—images with major 
fat suppression problems that make lesion identification 
unfeasible. Lesion visibility was scored by using: 0—lesion 
is not seen; 1—lesion is poorly seen, requiring T1-w post-
contrast images for identification; 2—lesion is visible, but 
not as conspicuous as in T1-w post-contrast images; 3—the 
lesion is easily visible, equivalent to T1-w post-contrast 
images. These variables were dichotomised for further sta-
tistical analysis. For uniformity of fat suppression, the score 
of 0 was opposed to scores 1 and 2 that were grouped (given 
that for either, fat suppression was not homogeneous). 
Regarding lesion visibility, scores of 0 were given to “non-
visible” lesions, while scores 1, 2 and 3 were considered as 
“visible”. The distribution of visible lesions by score was 
recorded. Additionally, the strength of agreement between 
STIR and SPAIR was assessed for the two variables.
Quantitative assessment
Using the STIR and dynamic contrast-enhanced images 
for visual guidance, fixed circular 0.25 cm2 regions-of-
interest (ROIs) were manually drawn on the b400 s/mm2 
diffusion images, and then copied on to the other b values 
and the ADC map. The ROIs were drawn in the lesions so 
as to only include the area with highest signal intensity. For 
Table 1  Scanning protocol for 
the DWI pulse sequences
DWI diffusion-weighted 
imaging, FOV field-of-view, 
NEX number of excitations, SS-
SE-EPI single shot-spin echo-
echoplanar imaging, TR/TE 
repetition time/echo time, TI 
inversion time
Parameters DWI
Sequence SS-SE-EPI SS-SE-EPI
Fat suppression STIR SPAIR
Orientation Sagittal Sagittal
TR/TE (ms) 4,900/108 4,900/106
TI (ms) 240 –
FOV (mm2) 250 × 250 250 × 250
Matrix 84 × 128 84 × 128
Slice thickness (mm) 5 5
Voxel size (mm3) 3 × 2×5 3 × 2×5
Number of slices 16 16
NEX 3 3
Bandwidth (Hz/pixel) 1,628 1,628
Scan time (min) 5:58 5:58
b values (s/mm2) 50, 200, 400, 600, 800, 1,000, 2,000, 
3,000
50, 200, 400, 600, 800, 
1,000, 2,000, 3,000
fibroglandular tissue demarcation, the ROI was positioned in 
the mid-sagittal slice, behind the nipple and avoiding fat. The 
selection of the b400 s/mm2 images was based on a compro-
mise of having image contrast between the lesion core and its 
outer limits, but still higher SNR than that of b1,000 s/mm2.
SNR and CNR for each type of lesion and normal fibro-
glandular tissue (measured on the contralateral breast) were 
calculated at b1,000 s/mm2 using the appropriate equations 
[15, 16]. According to Rahbar et al. [17], the CNR was 
considered to be positive when the lesion’s signal intensity 
was higher than normal background breast tissue.
Mean values of signal intensity, SNR, CNR and ADC 
were compared between DWI-ST IR and DWI-SPAIR 
for benign and malignant lesions, and normal fibroglandular 
tissue. The ADC cutoff values for each fat suppression tech-
nique were estimated. Diagnostic performance of the ADC 
values was also calculated for each fat suppression technique.
Statistical analysis
IBM SPSS 20.0 software was used to perform the statisti-
cal analysis. A descriptive analysis was used to characterise 
our sample. The McNemar test was adopted to evaluate 
the homogeneity of fat suppression and lesion visibility. 
For the two qualitative variables, the strength of agreement 
between STIR and SPAIR was assessed using the Kappa 
coefficient (k), classified as poor (<0.2); fair (0.21–0.4); 
moderate (0.41–0.6), good (0.61–0.8) and very good (0.81–
1.0) [18]. The Wilcoxon rank test was used to compare the 
mean values of signal intensity, SNR, CNR and ADC for 
each of the fat suppression techniques and tissues (nor-
mal fibroglandular tissue, benign and malignant lesions). 
The differences in the ADC values between benign and 
malignant lesions for each fat suppression technique were 
assessed by the Mann–Whitney test.
The ADC optimal cutoff point was selected based on 
the receiver operating characteristic (ROC) curve. Sensi-
tivity, specificity and accuracy were calculated for both fat 
suppression techniques. The area under the curve (AUC) 
was compared. Statistical significance was considered for 
p < 0.05.
Results
Subjects and lesions
From the 51 patients initially enrolled in this study, four 
were excluded due to the presence of motion artefacts 
on the DWI, which prevented image analysis. From the 
remaining 47 women, 38 were menopausal (mean age 
45.5 ± 2.1 years, range 30–64 years).
From the 52 lesions detected with the dynamic contrast-
enhanced pulse sequence, 47 were characterised by DWI-
STIR and DWI-SPAIR. Lesions smaller than 7.0 mm were 
not seen on the DW images, corresponding to two lobular 
carcinoma in situ with 6.0 mm, one epithelial proliferative 
lesion with 6.5 mm and two fibrocystic changes. Mean size 
was of 18.0 ± 11.0 mm, although malignant lesions were
larger than benign ones (23 ± 13 mm vs. 13 ± 5 mm).
Histological confirmation was obtained for all men-
tioned lesions following this study. Table 2 shows the 
lesion characteristics. Out of the 47 lesions identified in the 
DWI sequence, 25 were malignant tumours from which 11 
were ductal carcinoma and seven were invasive lobular car-
cinoma. The most frequent of the 22 benign lesions was the 
fibroadenoma (n = 9).
Qualitative assessment
The percentage of images with homogeneous fat sup-
pression was higher for DWI-STIR than for DWI-SPAIR, 
85.1 % (40/47) versus 72.3 % (34/47) (p = 0.03). There
was good accord between the two techniques, k = 0.64
(95 % CI 0.36–0.88).
Table 2  Main features of the lesions in the sample
DCE dynamic contrast enhancement, DWI-SPAIR diffusion-weighted 
imaging-spectrally attenuated inversion recovery, DWI-STIR diffu-
sion-weighted imaging-short tau inversion recovery, N absolute num-
ber, SD standard deviation
a Other malignant lesions (NOS—not otherwise specified)
Characteristics Mean ± SD or N
No. of lesions on DCE 52
No. of lesions on DWI-STIR 47
No. of lesions on DWI-SPAIR 47
No. of malignant lesions 25
Size of malignant lesions (mm) 23 ± 13
Malignant histopathological subtype
 Ductal carcinoma in situ (DCIS) 4
 Lobular carcinoma in situ (LCIS) 1
 Invasive ductal carcinoma (IDC) 11
 Invasive lobular carcinoma (ILC) 7
 Mucinous carcinoma 1
 Other malignant (NOS)a 1
No. of benign lesions 22
Size of benign lesions (mm) 13 ± 5
Benign histopathological subtype
 Fibroadenoma 9
 Epithelial proliferative lesion 4
 Papilloma 1
 Complex sclerosing lesion 4
 Fibrocystic changes 2
 Complex cystic lesion 2
All the lesions detected on DWI were visible on both 
sequences. Nine lesions were rated with score 3 in DWI-
SPAIR, and classified with score 2 in DWI-STIR. For 29 
lesions (61.7 %) the same score was achieved by both tech-
niques. A moderate agreement was found, with k = 0.43
(95 % CI 0.21–0.64).
Figure 1 illustrates the use of the two fat suppres-
sion techniques in the case of a 38-year-old woman with 
an invasive ductal carcinoma on the right breast (superior 
quadrant), near a large simple cyst.
Quantitative analysis
The signal intensity decreased with the increasing b values. 
Mean values were higher in the DWI-SPAIR for all b val-
ues (p = 0.001), and for both lesions and normal breast.
At b1,000 s/mm2, which is the most frequently used diffu-
sion-weighting factor, p values were p = 0.04, p = 0.001,
and p = 0.02 for fibroglandular tissue, benign and malig-
nant lesions, respectively. Malignant tumours presented the 
highest signal intensity as opposed to the normal fibrog-
landular gland. Table 3 displays results of the quantitative 
analysis of the data. DWI-SPAIR only evidenced higher 
SNR for benign lesions (p < 0.01). Both DWI sequences 
showed similar CNR for benign and malignant lesions. 
There were no differences between ADC values except for 
the normal fibroglandular tissue (p < 0.01). The AUC was 
similar for DWI-STIR and -SPAIR (p = 0.78). Both tech-
niques showed sensitivity of 84.0 %, but DWI-SPAIR evi-
denced slightly higher specificity and accuracy.
The larger AUC was obtained for the cutoff ADC values 
of 1.54 and 1.49 (×10−3 mm2/s), respectively, for DWI-
SPAIR and DWI-STIR. Two more false positives were 
found for DWI-STIR (two fibroadenomas, two fibrocystic 
changes, one epithelial proliferative lesion, one scleros-
ing lesion), than for DWI-SPAIR (two fibroadenomas, one 
fibrocystic change and one epithelial proliferative lesion). 
Both techniques detected four false-negative cases: one 
mucinous carcinoma, and three invasive ductal carcinoma 
for DWI-SPAIR; and one mucinous carcinoma, one ductal 
carcinoma in situ, and two invasive ductal carcinoma for 
DWI-STIR.
Discussion
Papers regarding breast DWI at 3.0 T are still scarce, but 
this field strength seems to be advantageous for characteris-
ing breast lesions [19–22]. Image quality is very important, 
as lesion characterisation and ADC quantification directly 
depend on the ability to locate it and measure its signal 
intensity.
As DWI is mostly based on echoplanar imaging, it 
is quite challenging at high field because B0- and B1 
Fig. 1  Thirty-eight-year-old woman with an invasive ductal carci-
noma (IDC) and a large cyst in the right breast. Morphological (left 
column) and DWI-STIR (diffusion-weighted imaging-short tau inver-
sion recovery) and -SPAIR (spectrally attenuated inversion recovery) 
images (b50 s/mm2) and the corresponding apparent diffusion coeffi-
cient (ADC) maps show a large tumour in the upper quadrant (arrow-
head) with diffusion restriction and low ADC. Susceptibility artefacts 
in the interface between the adipose and the fibroglandular tissues 
(black arrows), as well as in the anterior thoracic wall (white arrows) 
are far more evident on the DWI-SPAIR images
inhomogeneity-related artefacts are considerably amplified. 
They lead to areas of signal intensity dropout, image blur-
ring and ghosting, geometric distortion and chemical shift 
artefacts. Therefore, the fat suppression technique should 
be as robust as possible. As FatSat methods are more prone 
to artefacts [4, 6], water excitation, Dixon, STIR or SPAIR 
techniques may be preferred at 3.0 T. Also, recent scanners 
can apply dual-source RF excitation with independent RF 
shimming that improves signal homogeneity and fat sup-
pression by reducing the dielectric effects, thus enabling 
the use of short TRs and low RF absorption rate (SAR) [23, 
24].
In our study, there were no major fat suppression prob-
lems in the DWI datasets that prevented lesion identifica-
tion. To maximise scanning success rate, we have estab-
lished some strategies to improve image quality, such as 
the use of volume shimming, manual lipid frequency peak 
identification, small field-of-view and the use of paral-
lel imaging [2]. Despite potentially resulting in a slight 
decrease in SNR, parallel imaging shortens acquisition 
time [25] with no major impact on ADC values [2]. DWI-
STIR outperformed DWI-SPAIR in fat suppression homo-
geneity in six cases, which was most probably related to its 
higher insensitivity to B0 inhomogeneities and susceptibil-
ity artefacts [3–6].
Ninety percent of the lesions were detected in both 
sequences, in accordance to what was found by other 
authors [1, 26]. The fact that nine lesions were more easily 
visible on the DWI-SPAIR when compared to DWI-STIR 
is perhaps related to its higher SNR and CNR. Matsuoka 
et al. [19] found high visibility scores at 3.0 T even for 
lesions smaller than 10 mm. The minimum lesion size on 
DWI in this study, as defined by the longest dimension on 
the dynamic acquisition, was 7.4 mm, which is acceptable 
considering the 5-mm slice thickness. A decrease in the 
slice thickness to 3–4 mm could have enabled the detection 
of even those small lesions, although at the cost of lowering 
the SNR.
Normal fibroglandular tissue presented lower signal 
intensity when compared to lesions at b1,000 s/mm2, due 
to a less compact structure and good suppression of the 
fat component. We found higher signal intensity, SNR 
and CNR values on DWI-SPAIR when compared to DWI-
STIR, although not all statistically different, an excep-
tion being the SNR for benign lesions. Even though these 
results could perhaps be related to the variety of their his-
tological types, this can potentially be explained by the fat 
suppression technique itself [27, 28], as all other geometric 
and timing parameters were kept the same. Although these 
results require additional confirmation, it is known that 
SPAIR enhances the lesion-to-background contrast [29]. 
On the contrary, the STIR technique saturates other tissues 
with very similar T1 values analogous to that of fat. Moreo-
ver, most tissues recover more slowly than fat and, there-
fore, the SNR decreases.
As in other studies, malignant lesions presented higher 
SNR and CNR at 1,000 mm2/s when compared to benign 
ones in both sequences, due to their increased cellular 
components and diffusion restriction. Previous work from 
Bogner et al. [16] and Takanaga et al. [30] at 3.0 T found a 
Table 3  Comparison of signal-to-noise ratio, contrast-to-noise ratio 
and apparent diffusion coefficient at b1,000 s/mm2, in normal fibro-
glandular tissue, benign and malignant lesions, and diagnostic per-
formance of diffusion-weighted imaging (DWI)-spectrally attenuated 
inversion recovery and DWI-short-tau inversion recovery
ADC apparent diffusion coefficient, SNR signal-to-noise ratio, CNR contrast-to-noise ratio, DWI-SPAIR diffusion-weighted imaging-spectrally 
attenuated inversion recovery, DWI-STIR diffusion-weighted imaging-short tau inversion recovery, AUC area under the curve
* Statistically significant
DWI-SPAIR DWI-STIR p value
SNRnormal gland 15.8 ± 0.6 10.62 ± 0.6 0.16
SNRbenign lesions 17.3 ± 0.8 11.17 ± 0.5 <0.01*
CNRbenign lesions 1.1 ± 0.1 1.09 ± 0.08 0.12
SNRmalignant lesions 18.3 ± 0.3 16.84 ± 0.2 0.68
CNRmalignant lesions 1.2 ± 0.1 1.17 ± 0.2 0.08
ADCnormal gland (×10−3 mm2/s) 1.79 ± 0.29 1.88 ± 0.39 <0.01*
ADCbenign lesions (×10−3 mm2/s) 1.68 ± 0.39 1.72 ± 0.47 0.40
ADCmalignant lesions (×10−3 mm2/s) 1.19 ± 0.36 1.21 ± 0.437 0.35
Cutoff (×10−3 mm2/s) 1.54 1.49 –
Sensitivity 84.0 % 84.0 % –
Specificity 77.3 % 71.4 % –
Accuracy 80.9 % 78.3 % –
AUC 82.5 % (68.7–92.1 %) 81.3 % (67.1–91.3 %) 0.78
higher CNR for malignant lesions at b850 and b500 s/mm2, 
respectively. The histological type of the lesions or the fat 
suppression technique may explain these differences, as 
the authors used DWI-STIR and DWI-SPECIAL (spec-
tral inversion at lipid) (similar to SPIR) pulse sequences, 
respectively.
The ADC value is used to differentiate between benign 
and malignant breast lesions. The differences in the 
scanners’ hardware, magnetic field strength and imag-
ing protocol must be taken into account when com-
paring different studies. Previous studies from Mat-
suoka et al. [19] and Lo et al. [31] at 3.0 T reported 
ADC values for malignant lesions of 0.98 ± 0.16 and
1.01 ± 0.25 × 10−3 mm2/s, while mean ADC for benign
lesions was 1.47 ± 0.30 × 10−3 mm2/s [31]. Our results
are in agreement with these studies, with lower ADC for 
malignant lesions when compared to benign ones or normal 
fibroglandular tissue.
For quantitative ADC analysis, b1,000 s/mm2 is usually 
applied [32, 33] as it is considered to be optimal for breast 
tumour imaging, because it enables good suppression of 
normal mammary gland and higher signal intensity from 
lesions [25]. In a meta-analysis published by Chen et al. 
[34] for the subgroup of studies using b values of 1,000 s/
mm2, the ranges of minimum and maximum ADC values 
for malignant and benign lesions were 0.91–1.21 and 1.39–
1.61 (×10−3 mm2/s), respectively. Our results are similar
to the literature, although the mean ADC for the benign 
lesions in our sample is slightly higher than these, probably 
reflecting some degree of heterogeneity in their subtypes. 
The ADC values for the two fat suppression techniques 
were very similar except for the normal gland (p < 0.01). In 
our opinion, one should be careful when interpreting these 
preliminary results, as the sample size is small. Neverthe-
less, the most probable explanation is that spectral-selective 
methods such as SPAIR only suppress the ~3.4 ppm lipid 
signals, without affecting minor lipid peaks near the water 
resonance, whereas STIR suppresses all tissues that have 
short T1 and low-ADC fat constituents, thus increasing the 
ADC.
The cutoff values showing the higher AUC were 1.54 
and 1.49 (×10−3 mm2/s), respectively, for DWI-SPAIR
and DWI-STIR. Sensitivity was 84.0 % for both fat sup-
pression techniques; with specificity and accuracy rates of 
77.3 and 71.4 %, and 80.9 and 78.3 %, respectively, which 
is slightly lower than other authors have reported [31, 32, 
35, 36]. This may be related to the differences in the DWI 
pulse sequence parameters.
Both cutoff points resulted in a low number of false-
negative and false-positive cases. Two more false positives 
were found for DWI-STIR (two fibroadenomas, two fibro-
cystic changes, one epithelial proliferative lesion, one scle-
rosing lesion) than for DWI-SPAIR (two fibroadenomas, 
one fibrocystic change and one epithelial proliferative 
lesion). The increased cellularity in some benign lesions 
was the probable cause for the false-positive cases. The 
additional complex sclerosing lesion found when the DWI-
STIR cutoff point was 1.49 × 10−3 mm2/s may be asso-
ciated to the presence of different fibrotic degree and pro-
liferative cell activity that constrain water diffusion and 
decrease the ADC value [37–40] that, in our study, was 
similar to malignant lesions.
Concerning the false negatives, both techniques 
showed four misclassified lesions, three of which were 
misleading lesions in the same patients (one mucinous 
carcinoma and two invasive ductal carcinomas). The high 
ADC of mucinous carcinoma may be due to the presence 
of mucus in the extracellular space and the decreased cel-
lularity [3, 37], whereas invasive ductal carcinomas are 
often heterogeneous and have haemorrhagic focus. The 
false negative on DWI-STIR was a low-grade ductal car-
cinoma in situ, which may have ambiguous signal inten-
sity, even at higher b values, due to rapid signal decay 
[10, 26, 41].
There are certain limitations in our study. First, the small 
sample size will require future work to confirm these pre-
liminary results. Second, the scanning time for the clinical 
protocol and both the DWI-STIR and -SPAIR sequences 
was almost 40 min, resulting in a few cases of motion arte-
facts. However, an optimised acquisition with only two b 
values (b50 and 1,000 s/mm2) would enable reducing the 
TE and shorten the acquisition time. Although performing 
two unilateral acquisitions may increase the scanning time, 
the use of small field-of-view for sagittal imaging enables 
good spatial resolution, better volume shimming and less 
magnetic susceptibility phenomena.
To further complement our results, a comparative analy-
sis of nonparallel imaging will be performed, to check its 
benefit on image quality. Additionally, it would also be 
desirable to test the performance of the slice-selection gra-
dient reversal method for fat suppression [42]. This method 
seems promising, achieving homogenous fat suppression 
with reduced acquisition time and SAR, which is particu-
larly beneficial at high field strength.
Even though STIR enabled more homogeneous fat sup-
pression, SPAIR provided better visibility for some lesions. 
The SNR and CNR were higher for DWI-SPAIR, although 
not statistically significant except for benign lesions. ADC 
values for malignant and benign lesions were similar. Spec-
ificity and accuracy were slightly higher for DWI-SPAIR. 
If the DW images were to be used on their own, more than 
81 % of the lesions would be correctly diagnosed. In con-
clusion, STIR- and SPAIR-based DW images were suited 
to identify and characterise breast lesions at 3.0 T. Future 
work will include a higher number of lesions to confirm 
these preliminary results.
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